2Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina: comparison witht propranolol in patients with stable angina. Trimetazidine European Multicenter study Group. Br J Clin Pharmacol, 1994,3:279 ～ 288 被引量：1
3Kantor PF, Lucien A, Kozak R, et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long - chain 3- ketoacyl coenzyme A thiolase. Circ Res, 2000, 86(5) :580 ～ 588 被引量：1
4Mody FV, Singh BN, Moihuddin IH,et al. Trimetazidine - induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography. Am J Cardiol, 1998, 82:42K～49K 被引量：1
5Lopaschuk GD, Kozak R. Trimetazidine inhibits fatty acid oxidation in the heart. J Mol Cell Cardiol, 1998, 30:A122 被引量：1
6Opie LH, Boucher F. Trimetazidine and myocardial ischemic contracture in isolated rat heart. Am J Cardiol,1995, 75:38B ～ 40B 被引量：1
7Nandakumar Sambandam PhD,Gary D. Lopaschuk PhD,Roger W. Brownsey PhD,Michael F. Allard BSc, MD. Energy Metabolism in the Hypertrophied Heart[J] 2002,Heart Failure Reviews(2):161～173 被引量：1
8Andrew A. Wolff,Heschi H. Rotmensch,William C. Stanley,Roberto Ferrari. Metabolic Approaches to the Treatment of Ischemic Heart Disease: The Clinicians’ Perspective[J] 2002,Heart Failure Reviews(2):187～203 被引量：1
